Top Melbourne, Victoria Healthtech Companies (33)
For over 20 years, we’ve been redefining how life- and mission-critical industries enable, control, and monitor digital identities to deliver fast access, improve security, and ensure compliance. Customer success is our DNA, which is why we’re trusted by the most prominent healthcare and enterprise organizations in 45 countries.
Mable is a health-tech platform where people looking for disability and aged care support connect with independent support workers in their community. As one of Australia’s fastest-growing scale-ups, we think big to spearhead change in our sector. We're passionate about inclusivity and giving choice and control back to those who need it. Mable launched in 2014 when co-founder Peter Scutt teamed up with friend and colleague Tony Charara after struggling to find the right home care solution for his parents. Today, Australia’s largest and most diverse community of independent support workers has provided over 13 million hours of support on Mable so everyone can live their kind of independence. #mykindofindependence
InterSystems has been the information engine behind the world's most important applications in healthcare, business and government for over 40 years. Our software products provide advanced data management, integration, and analytics technologies used daily by millions of people in 80+ countries.
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed and manufactured. To learn more, visit www.modernatx.com. This Moderna page is not the appropriate place to report adverse events (side-effects) for any products. If you are or someone you know is experiencing a side effect, please reach out to your healthcare professional. Moderna is continuously monitoring the safety of its products. We encourage you to report any side effects directly to us at 1‑866‑MODERNA (1‑866‑663‑3762).
Medtronic is a global healthcare solutions company operating in approximately 160 countries. We are committed to improving lives through our medical technologies, services, and solutions. Since our beginning, 60 years ago, our Mission has remained the same: to alleviate pain, restore health, and extend life for people around the world. The Mission is our ethical framework and inspirational goal guiding our day-to-day work. It reminds us that our efforts are transforming millions of lives each year. To meet the needs of patients and healthcare professionals around the globe, we operate from more than 370 locations in approximately 160 countries.
Montu is Australia's leading health tech business revolutionising the alternative health landscape. Montu has built an integrated ecosystem, which streamlines the experience for patients end-to-end, and sets new standards. The company is committed to improve the lives of millions of patients
We’re Medmate. Nice to meet you. We take the inconvenience and awkwardness out of pharmacy visits. Book a consultation with a doctor or get a script all online. It's fast, easy and convenient. Medmate was developed by doctors and pharmacists and born out of a desire to take the burden out of pharmacy shopping and make life that little bit easier for Australians. Get your hands on all pharmacy essentials from thousands of pharmacies Australia wide, anywhere and anytime. Shop online with Medmate today.
Mesoblast (ASX:MSB; Nasdaq:MESO) is developing and commercializing allogeneic cellular medicines to treat serious and life-threatening inflammatory diseases with significant, unmet medical needs. The Company's Phase 3 off-the-shelf mesenchymal lineage cell product candidates are: • RYONCIL™ (remestemcel-L) for steroid-refractory acute graft versus host disease (acute GVHD) • Remestemcel-L for moderate to severe acute respiratory distress syndrome (ARDS) due to COVID-19 infection • REVASCOR® for advanced chronic heart failure, and • MPC-06-ID for chronic low back pain due to degenerative disc disease. The Company’s proprietary manufacturing processes yield industrial-scale, cryopreserved, off-the-shelf, cellular medicines. These cell therapies, with defined pharmaceutical release criteria, are planned to be readily available to patients worldwide. Mesoblast’s approach to product development is to ensure rigorous scientific investigations are performed with well-characterized cell populations in order to understand mechanisms of action for each potential indication. Extensive preclinical translational studies guide clinical trials that are structured to meet stringent safety and efficacy criteria set by international regulatory agencies. All trials are conducted under the continuing review of independent Data Safety Monitoring Boards comprised of independent medical experts and statisticians. Mesoblast has an extensive patent portfolio comprising approximately 1,000 patents and patent applications with protection extending through 2040 in all major markets. This intellectual property portfolio covers composition of matter, manufacturing, and therapeutic applications of mesenchymal lineage cells. The Company believes this patent estate provides strong global protection.
Over the past two decades, has built Australia's leading marketplace connecting Business & Healthcare Providers. We create innovative solutions using our medEbridge platform and our marketplace of healthcare providers to enable you to achieve your business objectives. medEbridge allows businesses to access GPs, Specialists, Nurses, Allied Health Providers and more. Our business customers include life insurers, compulsory third party insurers, workers compensation insurers, legal firms, employers and government agencies. Current information and services procured include treating doctor reports, medical file copies, independent medical examinations, peer reviews, medical advice, health assessments, eForms, vaccinations and tele-interviews
Smileyscope is a multi-award winning digital therapeutics company with proprietary technology that reframes medical procedures using choreographed virtual-reality (VR) experiences to help reduce patient pain and anxiety, and improve the overall patient experience. Our vision is to expand the frontiers of patient-centered care, improving the moments that matter most. Smileyscope VR is the first regulatory body approved VR product for medical use and is clinically proven to reduce patient pain, anxiety and the need for restraints. It is being used by clinicians across a range of medical procedures such as needle procedures, wound dressings, anaesthetic induction, using nitrous oxide, awaiting theatre, and plaster cast applications/removals. Smileyscope VR has been designed by clinicians, for clinicians. It is very easy to learn and fits seamlessly into the clinical workflow. It has been incredibly well received by clinicians, patients and caregivers. “It’s a game changer. Patients are getting better care and needing less sedation and pain medication” - Anaesthetist “My child has had over 300 procedures. This was the first time he has not cried” - Parent of a 5yr old patient “Smileyscope brings out the joy in work. It can turn a traumatic procedure into a pleasant one” – Emergency Paediatrician Smileyscope is operating in Australia, USA, UAE, Europe and UK. Smileyscope VR is being used in leading hospitals in Australia, USA and UAE. For non-USA based queries, please contact [email protected] to learn more. For USA based queries, please contact [email protected] to learn more
Umps is a Victorian health-tech company redefining the personal alarm industry to help older adults and NDIS participants stay safe, independent and healthy at home for longer. Our flagship product, the Umps Link Home Alarm, is the culmination of six years of dedicated research and development, designed in collaboration with some of the largest aged care providers in Victoria and older adults. The personal alarm pendant weighs just 12 grams, doesn’t require charging and is fully reimbursable under the Home Care Package Program, geat2GO and the NDIS. Umps is also transforming aged care delivery by partnering with home care providers and retirement villages. Our innovative monitoring and communication solutions are enabling providers to deliver proactive, efficient care at scale. Umps' technologies have been installed in thousands of households across Australia and New Zealand, earning recognition with a prestigious Good Design Award.
PKG Health believes every person with a neurological condition deserves to live their best life every day. We leverage the world’s largest body of clinical evidence in neurology, to create and deliver precision medicine by accelerating the research, approval and adoption of treatments. Its lead product, the Parkinson's KinetiGraph®(PKG® or Personal KinetiGraph® in the US), has been developed by neurologists at the world-renowned Florey Institute of Neuroscience in Melbourne, Australia. The PKG® enables the precise monitoring, quantification and reporting of movement patterns of neurological diseases including bradykinesia, dyskinesia, tremor and immobility. Our PKG technology: • Technically de-risked and established in market – over 6,000,000 hours of continuous Parkinson’s monitoring delivered to date, representing more than 25,000 patient PKGs • Changes clinical decisions more than 50% of the time • Boasts significant key opinion leader support • Is underpinned by robust clinical validation and regulatory clearance through FDA 510(k) in the USA, CE mark in Europe, TGA Class IIA ARTG 236583 listed The PKG® system is being used in clinics across the U.S., Europe and Asia Pacific, enabling better clinical outcomes and reducing health care costs across the Parkinson’s disease continuum. GK continues to pursue partnerships with major pharmaceutical and medical technology companies to help measure the efficacy of new and advanced therapies for one of the world’s most widespread movement disorders. For further information, please visit our website, www.pkgcare.com
Advancing the world’s transition to AI-supported healthcare.
Aravax is a clinical stage biotechnology company developing a novel peptide-based immunotherapy, PVX108, for the treatment of peanut allergy. Aravax is striving to improve the lives of patients living with peanut allergies by developing a therapy that precisely targets the underlying cause of disease, bringing benefits in safety and convenience.
Since 1993, EPAM Systems, Inc. (NYSE: EPAM) has leveraged its software engineering expertise to become a leading global product development, digital platform engineering and top digital and product design agency. Through our ‘Engineering DNA’ and innovative strategy, consulting, and design capabilities, EPAM works in collaboration with its clients to deliver next-gen solutions that turn complex business challenges into real business outcomes. EPAM’s global teams serve clients in more than 55 countries across five continents. We've been recognized as a Built In Best Places to Work (2024-2025), Glassdoor Best Place to Work (2023-2025), and named a Top 100 Most Loved Workplace by Newsweek (2021 - 2024).
Lenexa Medical is an Australian-based MedTech company that has developed the LenexaCARE technology to empower clinicians to deliver targeted, long-term solutions for personalised pressure injury prevention and patient monitoring. Pressure injuries are mostly preventable, however affect millions of people globally each year whilst costing healthcare systems billions of dollars worldwide. In 2020, Australian public hospitals spent over $9 billion to address the issue. The LenexaCARE system consists of an ultra-thin fabric with in-built sensing capabilities and smart software for detecting and monitoring patient position, posture, and presence. By providing clinicians with non-subjective data to monitor positioning and presence of patients over time, LenexaCARE allows decisions to be made based on an individual’s unique profile and history on the mattress. The novel LenexaCARE technology will not only reduce the cost associated with pressure injury treatments and bed stays, but more importantly help to ease the pain and suffering for patients and their families.
HotDoc is Australia's largest and most trusted patient engagement platform. We take pride in helping over 21,000 practitioners connect with more than 9 million patients. The HotDoc platform includes: online bookings, recalls, reminders, check-in, place in queue, online processing of repeat prescription requests, and Inform (a tool designed to encourage patients to take a more proactive interest in preventative health and chronic disease management). HotDoc also provides free monthly webinars where practice managers, GPs, nurses and medical receptionists can earn CPD points. With over 20,000 registrations last year alone, HotDoc's webinar series is the highest attended healthcare webinar series in Australia. Interested in a career at HotDoc? Visit our careers page: https://apply.workable.com/hotdoc/
Lyrebird Health is an AI medical scribe that securely listens in the background throughout your consultation, then intelligently generates a note tailored to your style, ready to transfer into the medical record. We're on a mission to automate all non-patient-facing work so that doctors can spend more time with patients and less time on paperwork.
Zipline is a "Fast100" startup automating 'Frontline Compliance' workflows HealthCare organisations in Australia & USA. Loved by customers in Health Care such as St Vincent’s, Regis, Calvary and many more. Our Customer Experience RateIt product captures in-the-moment customer sentiment for customers such as Adidas, Coles, Mitre10 and many more. Our 6Q product provides weekly Employee Pulse Surveys, tracking team mood for RAC, Seven West Media and many more. And YES we’re hiring… so please reach out to Jack - our friendly head of talent - to chat.
Seer is a medical technology company on a mission to give people more control of their most valuable assets—their health and their time—by reimagining how and where they undergo long-term clinical monitoring. Seer's products and services are focused on solving the problems related to the early and accurate diagnosis of epilepsy. Seer’s flagship suite of technologies, offered through a provider partnership service called Seer Home, is an FDA-cleared Class II medical device that delivers a revolutionary home-based video-EEG-ECG monitoring solution for seizure disorders and related conditions.
Work Your Passion. Live Your Purpose.
